The Patent Finder

Hangzhou Solipharma Co., Ltd.

Also on record
Records under this name other than the patents Hangzhou Solipharma Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Back to Hangzhou Solipharma Co., Ltd.

PatentTitleStatus Expires Confidence
US 11,427,528Fenofibrate Crystalline Form and Manufacturing Method Thereof
Lapsed on the fee record
Ended Aug 30, 2026 · High confidence
Lapsed on the fee recordEnded Aug 30, 2026High confidence
US 11,286,259Co-crystals of ribociclib and co-crystals of ribociclib monosuccinate, preparation method therefor, compositions thereof, and uses thereof
Lapsed on the fee record
Ended Mar 29, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 29, 2026From the USPTO record
US 9,884,856Crystal form of Dabrafenib mesylate and preparation method thereof
Lapsed on the fee record
Ended Feb 6, 2026 · From the USPTO record
Lapsed on the fee recordEnded Feb 6, 2026From the USPTO record
US 11,236,077Fruquintinib eutectic crystal, preparation method therefor, composition, and uses thereof
Lapsed on the fee record
Ended Feb 1, 2026 · From the USPTO record
Lapsed on the fee recordEnded Feb 1, 2026From the USPTO record
US 11,208,382Entinostat-containing compound, crystal form of compound thereof, and preparation method therefor and pharmaceutical composition thereof
Lapsed on the fee record
Ended Dec 28, 2025 · From the USPTO record
Lapsed on the fee recordEnded Dec 28, 2025From the USPTO record
US 11,117,875Crystalline forms, preparation methods and pharmaceutical compositions of ozanimod
Lapsed on the fee record
Ended Sep 14, 2025 · From the USPTO record
Lapsed on the fee recordEnded Sep 14, 2025From the USPTO record
US 11,111,248Crystal form of 2-(6-methyl-pyridin-2-yl)-3-yl-[6-amido-quinolin-4-yl]-5,6-dihydro-4H-pyrrolo[1,2-B]pyrazole, preparation method therefor and pharmaceutical composition thereof
Lapsed on the fee record
Ended Sep 7, 2025 · From the USPTO record
Lapsed on the fee recordEnded Sep 7, 2025From the USPTO record
US 10,995,083Cocrystal of 2-(6-methyl-pyridine-2-yl)-3-yl-[6-amide-quinoline-4-yl]-5,6-dihydro-4H-pyrrole[1,2-b]pyrazole, preparation method therefor, and pharmaceutical composition
Lapsed on the fee record
Ended May 4, 2025 · From the USPTO record
Lapsed on the fee recordEnded May 4, 2025From the USPTO record
US 10,954,210Crystal form of tipifarnib and preparation method and pharmaceutical composition thereof
Lapsed on the fee record
Ended Mar 23, 2025 · From the USPTO record
Lapsed on the fee recordEnded Mar 23, 2025From the USPTO record
US 10,899,767Crystal form of ACP-196, preparation method therefor and pharmaceutical composition thereof
Lapsed on the fee record
Ended Jan 26, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jan 26, 2025From the USPTO record
10 of 20 patents shown.
Pro members see all 20.
Pro members: see all 20 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited